HARROW HEALTH SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Harrow Health To Contact Him Directly To Discuss Their Options

NEW YORK, Feb. 25, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Harrow Health, Inc. (“Harrow Health” or the “Company”) (NASDAQ: HROW). If you suffered losses exceeding $50,000 investing in Harrow Health stock…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.